Navigation Links
New type of drug shows promise in attacking melanoma in an innovative way
Date:9/26/2007

Barcelona, Spain: An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients.

New research presented today (Wednesday) at the European Cancer Conference (ECCO 14) in Barcelona found that giving the new drug in addition to chemotherapy more than doubled the amount of time patients survived without progression of their cancer.

The study, according to Dr Anthony Williams, vice president of clinical research at Synta Pharmaceuticals Corp. in Lexington, Massachusetts, USA, included 81 patients with metastatic melanoma. Of those, 28 received treatment with the chemotherapy drug paclitaxel alone and 53 received paclitaxel plus the new drug, STA-4783.

The median progression free survival was 1.8 months in the group who got chemotherapy alone, but 3.7 months in the group who got the combination, Williams said. This doubling in progression free survival is impressive for this cancer, and the result was achieved without substantial additional toxicity.

He added: Progression-free survival was linked to improvements in overall survival. Patients on the experimental combination survived on average for 12 months after being diagnosed, while those getting only paclitaxel survived on average 7.8 months. This is the first time an improvement in survival has been seen in a randomised, double-blind, multi-centre controlled trial for metastatic melanoma.

The drug is the first in a new class called oxidative stress inducers. It works by increasing the amount of reactive oxygen species (ROS), such as hydrogen peroxide and superoxide, in cells. When the level exceeds the antioxidant capacity of cells, the cells are in a state of oxidative stress. All cells have some low level of ROS, but cancer cells naturally operate with a higher level of ROS and oxidative stress relative to normal cells. However, too much oxida
'/>"/>

Contact: Emma Ross
rosswrite@mac.com
34-932-308-832
ECCO-the European CanCer Conference
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Gene Therapy shows promise in treating Hemophilia
3. New Prostate Cancer Vaccine Shows Promise
4. Leukemia pill shows promise against stomach cancer
5. Stent shows promise in keeping arteries open
6. Drug to treat lung cancer shows promise
7. Latest drug shows promise in multiple myeloma
8. AIDS vaccine falls short but shows some promise
9. Ebola Treatment Shows Promise
10. SARS vaccine shows promise in Animal Testing
11. New Drug Shows Significant Improvement In HIV-related Heart Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows all about ... can be treated. , A medically retired Army veteran, ... platoon sustained multiple attacks resulting in five casualties. After ... PTSD and honorably discharged from the Army. , “I ... myself from my friends and family,” recalled O’Farrell, who ...
(Date:9/23/2014)... By Karen Pallarito ... -- Imagine if doctors and hospitals got paid for providing ... consumers had better data for making informed health choices. ... health system is headed. The report, from the IMS ... of change" -- recent events expected to alter the delivery ...
(Date:9/23/2014)... 2014 What information do patients ... Quality Forum (NQF) released a report ( http://bit.ly/1DwekE9 ... an infographic ( http://bit.ly/1tX3lzA ) resulting from an ... how patients define affordability, and what information and ... best possible healthcare at the lowest possible cost. ...
(Date:9/23/2014)... A recent Oregon survey about an exercise DVD that ... routine of elementary school students found it had a ... and offered clear advantages for overly sedentary educational programs. ... produced by the Healthy Youth Program of the Linus ... nationally. , Brain Breaks leads children in 5-7 minute ...
(Date:9/23/2014)... 23, 2014 Trevera provides multiple ... Included are Oracle Managed Services , Oracle ... all versions of Oracle E-Business Databases and ... , Trevera has announced a significant enhancement to ... help with their software technology management, project management, ...
Breaking Medicine News(10 mins):Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... Swaroop Rani Nehru Hospital (SRN hospital) has resumed function, ... //. Two old dialysis machines have been repaired and ... ,Following inspection by the Medical Council of India ... machines. The patients are being charged for Rs 500 ...
... study published in PLoS Pathogens says that researchers have ... bacterium, which belongs to the family Acetobacteraceae is a ... the vinegar-making industry. ,The bacterium was identified ... is a rare genetic disorder that compromises the immune ...
... For the first time researchers have studied deeply about fat ... in the heart .Research has now revealed that these Fat ... of heart disease. University of Iowa researchers have revealed that ... ,Fat cells, once upon a time, were thought to have ...
... vegetables in your diet helps you to have fewer wrinkles ... // ,People with a normal diet can make ... red paprika in their meals, German magazine The Dermatologist said ... oxygen molecules - are a major factor in premature skin ...
... to a new study, lack of sleep in children, ... the University of Laval's faculty of medicine studied 422 ... the weight, height, and waist size of each participant. ... lifestyle and socio-economic status through phone interviews with their ...
... with cancer are interested in finding about latest treatments ... support //, reveals a new cancer study. Clive Seale, ... that cancer reaction is linked to gender. The findings ... to cancer support groups that help cancer patients. ...
Cached Medicine News:Health News:Fat cells lethally connected to heart disease 2Health News:Gender Difference In Reaction To Cancer 2
(Date:9/23/2014)...  SI-BONE, Inc., a medical device company that pioneered ... a minimally invasive surgical (MIS) device indicated for fusion ... U.S. Patent and Trademark Office has awarded the company ... fixation and fusion of bone.  This newly issued patent ... may be placed from one bone across a joint ...
(Date:9/23/2014)... NEW YORK , September 23, 2014 ... nouvelle solution Face2Gene améliorée lors d,une série ... http://www.fdna.com ), pionnier dans le domaine de ... exposera sa solution au stand n° 1035 lors ... à San Diego , ...
(Date:9/23/2014)... , Sept. 23, 2014   MedNet Solutions , a ... systems, is pleased to announce that it will once again ... Management (SCDM) Annual Conference, to be held this year from ... , Nevada. MedNet team members, in conjunction with representatives from ... who will also be in attendance, will be providing demonstrations ...
Breaking Medicine Technology:SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2
... facilitates stomal insertion., ,Adult TTS™ Adjustable ... trach tie, disconnect wedge, and obturator/introducer device., ... are intended for temporary use until the ... be obtained. Not for home care use. ...
... Lo-Profile™ tracheostomy tube is cosmetically pleasing ... styles of inner cannula come with ... cannula and a 15 mm ISO ... The semi-reusable inner cannula may be ...
... mm ISO termination for easy ventilator circuit ... place. , ,Clearly the softer choice ... , ,The Portex® flexible disposable inner ... polyvinyl chloride, providing a softer and more ...
... TRACH CARE Dual Lumen, allows ... the patient end of the ... Swivel Elbow and Direction Tip ... Offers multiple tracheostomy sizes, French ...
Medicine Products: